How targeted pharmacy engagement boosted PCSK9 therapy persistence

PCSK9 inhibitors provide vital cardiovascular protection when statins fail, but patient adherence is challenging. High abandonment rates, low refill persistence, and costly drop-offs impact outcomes and commercial success in chronic care.

This case study shows how a leading pharmaceutical brand partnered with MedAdvisor Solutions to launch a precision-targeted adherence program across 25,900+ pharmacies, achieving results:

• 15.5% rise in injections per patient, adding 22.5 therapy days
• 26% higher first-fill pickup rates with prevention messaging
• 13.6% increase in average refills over six months

Learn how predictive intelligence and pharmacy support improve adherence.